Glucose Intolerance As the Key Risk Factor for Metabolic Syndrome

Overview

Journal J Clin Hypertens (Greenwich)

Specialty Cardiology & Vascular Diseases

Date 2017 Sep 19

PMID 28921923

Citations 1

Authors

Guido Grassi

Affiliations

Soon will be listed here.

Citing Articles

Glucose intolerance as the key risk factor for metabolic syndrome.

Grassi G J Clin Hypertens (Greenwich). 2017; 19(9):848-849.

PMID: 28921923 PMC: 8030892. DOI: 10.1111/jch.13063.

References

Grassi G, Facchini A, Trevano F, DellOro R, Arenare F, Tana F . Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005; 46(2):321-5. DOI: 10.1161/01.HYP.0000174243.39897.6c. View

Grassi G, Giannattasio C, Failla M, Pesenti A, Peretti G, Marinoni E . Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension. 1995; 26(2):348-54. DOI: 10.1161/01.hyp.26.2.348. View

Rowe J, Young J, Minaker K, Stevens A, Pallotta J, Landsberg L . Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981; 30(3):219-25. DOI: 10.2337/diab.30.3.219. View

Huggett R, Burns J, Mackintosh A, Mary D . Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension. 2004; 44(6):847-52. DOI: 10.1161/01.HYP.0000147893.08533.d8. View

Grassi G, Mark A, Esler M . The sympathetic nervous system alterations in human hypertension. Circ Res. 2015; 116(6):976-90. PMC: 4367954. DOI: 10.1161/CIRCRESAHA.116.303604. View

Grassi G, Arenare F, Quarti-Trevano F, Seravalle G, Mancia G . Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Prog Cardiovasc Dis. 2009; 52(1):31-7. DOI: 10.1016/j.pcad.2009.05.007. View

Kosch M, Barenbrock M, Kisters K, Rahn K, Hausberg M . Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients. J Hypertens. 2002; 20(3):501-8. DOI: 10.1097/00004872-200203000-00026. View

Grassi G . Glucose intolerance as the key risk factor for metabolic syndrome. J Clin Hypertens (Greenwich). 2017; 19(9):848-849. PMC: 8030892. DOI: 10.1111/jch.13063. View

Bruno R, Ghiadoni L, Seravalle G, DellOro R, Taddei S, Grassi G . Sympathetic regulation of vascular function in health and disease. Front Physiol. 2012; 3:284. PMC: 3429057. DOI: 10.3389/fphys.2012.00284. View

10.

Grassi G, DellOro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F . Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005; 48(7):1359-65. DOI: 10.1007/s00125-005-1798-z. View

11.

Trevano F, Seravalle G, Macchiarulo M, Villa P, Valena C, DellOro R . Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. J Hypertens. 2017; 35(8):1685-1690. DOI: 10.1097/HJH.0000000000001370. View

12.

Scherrer U, Sartori C . Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 1997; 96(11):4104-13. DOI: 10.1161/01.cir.96.11.4104. View

13.

Brunner E, Hemingway H, Walker B, Page M, Clarke P, Juneja M . Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002; 106(21):2659-65. DOI: 10.1161/01.cir.0000038364.26310.bd. View

14.

Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, Pucci L . Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension. 2007; 51(2):440-5. DOI: 10.1161/HYPERTENSIONAHA.107.103093. View

15.

Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella M, DellOro R . Heart rate as marker of sympathetic activity. J Hypertens. 1998; 16(11):1635-9. DOI: 10.1097/00004872-199816110-00010. View

16.

Rodrigues S, Cepeda F, Toschi-Dias E, Dutra-Marques A, Carvalho J, Costa-Hong V . The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome. J Clin Hypertens (Greenwich). 2017; 19(9):840-847. PMC: 8030868. DOI: 10.1111/jch.13060. View

17.

Palatini P, Agabiti Rosei E, Casiglia E, Chalmers J, Ferrari R, Grassi G . Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. J Hypertens. 2016; 34(5):813-21. DOI: 10.1097/HJH.0000000000000865. View

18.

Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G . Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990; 70(4):963-85. DOI: 10.1152/physrev.1990.70.4.963. View

19.

Hamburg N, Larson M, Vita J, Vasan R, Keyes M, Widlansky M . Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2007; 101(1):82-8. PMC: 2214853. DOI: 10.1016/j.amjcard.2007.07.053. View

20.

Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, NICOD P . Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993; 92(1):147-54. PMC: 293552. DOI: 10.1172/JCI116542. View